UPDATE 2-Novartis to supply Zelnorm for U.S. restricted use

(Reuters) - ZURICH, July 27 - Swiss drugmaker Novartis
said on Friday it would make bowel drug Zelnorm
available to U.S. patients on a restricted basis after pulling
the product from the market at the request of regulators.




Novartis said it had established a restricted access
programme for Zelnorm in cooperation with U.S. regulators so
that patients in need of the drug can be considered for
treatment.


Read more at Reuters.com Government Filings News

European Stocks Advance; SAP, Roche, Vodafone, Actelion Lead the Gains

(Bloomberg) -- European stocks rose for the first
time in three days after profit from SAP AG and Roche Holding AG
beat analysts' estimates.

SAP and Roche joined Novartis AG among members of the Dow
Jones Stoxx 50 Index to report better-than-expected earnings so
far in this earnings season. Vodafone Group Plc gained after the
mobile-phone company said it added more subscribers than analysts
anticipated. Actelion Ltd. rallied the most in two years after
the biotechnology company said net income almost doubled.


Read more at Bloomberg Stocks News